Global Life Technologies

Global Life Technologies is a healthcare company specializing in infection prevention through its flagship brand, Nozin. The company's primary product, Nozin Nasal Antiseptic, is used for nasal decolonization to reduce the risk of healthcare-associated infections and surgical site infections. By targeting the nose as a primary reservoir for pathogens like Staphylococcus aureus, Global Life Technologies provides a non-antibiotic alternative to traditional decolonization methods. Their solutions are widely adopted in hospitals and clinical settings to improve patient safety and reduce the reliance on mupirocin. The company's programs focus on sustainable, cost-effective infection control strategies for both patients and staff.